<DOC>
	<DOCNO>NCT01278212</DOCNO>
	<brief_summary>The goal study explore safety , effectiveness , quality life , cost effectiveness accelerate hypofractionated radiotherapy ( AHF-RT ) treatment lumpectomy patient early stage breast cancer .</brief_summary>
	<brief_title>Accelerated Hypofractionated Radiotherapy ( AHF-RT ) Treatment Breast Cancer</brief_title>
	<detailed_description>The traditional radiation treatment schedule patient lumpectomy early stage breast cancer 15 30 treatment deliver day 3 6 week . This treatment schedule inconvenient costly elderly , rural , uninsured , minority patient . This study evaluate new radiation treatment schedule call whole-breast accelerate hypofractionated radiotherapy ( AHF-RT ) . AHF-RT delivers higher dos radiation few treatment traditional radiation therapy . The AHF-RT treatment course complete 5 radiation treatment deliver week 5 week . The purpose study determine accelerate hypofractionated radiotherapy ( AHF-RT ) safe , effective , convenient , less costly alternative traditional radiation offer chance cure additional side effect .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Only woman satisfy follow condition eligible study . 1. must consent study must sign approve consent form conform federal institutional guideline 2. must least 21 year old 3. must stage 0 , I , II breast cancer 4 . On histological examination , tumor must ductal carcinoma situ ( DCIS ) invasive adenocarcinoma breast . 5 . Surgical treatment breast must breast conserving surgery ( BCS ) . The margin resect specimen must histologically free tumor ( include DCIS component ) . Reexcision surgical margin permit . 6 . Gross disease may unifocal multifocal pathologic ( invasive and/or DCIS ) tumor size excise negative margin . 7 . Patients invasive breast cancer require axillary stag include sentinel node biopsy alone ( sentinel node negative ) , sentinel node biopsy follow axillary dissection sample minimum total 6 axillary node ( sentinel node positive ) , axillary dissection alone ( minimum 6 axillary node ) . Axillary staging require patient DCIS . 8. must begin adjuvant therapy ( chemotherapy radiotherapy ) within 9 week follow last surgery breast cancer ( lumpectomy , reexcision margin , axillary staging procedure ) 9 . Patients must usual customary hormone receptor ( ER/PR ) estrogen receptor ( ER ) analysis perform primary tumor prior enrollment . Patients invasive disease must HER2 receptor status determine ( positive negative ) immunohistochemistry ( IHC ) and/or fluorescent insitu hybridization ( FISH ) . 10 . At time study enrollment , patient must history &amp; physical exam within 4 month bilateral mammogram within 6 month . 11 . Patients history nonbreast malignancy eligible diseasefree 5 year prior enrollment deem physician low risk recurrence . Patients follow cancer eligible diagnose treat within past 5 year : carcinoma situ cervix , carcinoma situ colon , melanoma situ , basal cell squamous cell carcinoma skin . 12 . Patients must live county designate Appalachian and/or rural Kentucky Cancer Registry Criteria ( see list ) and/or must hold primary residence least 10 mile nearest radiation facility . Patients fit criterion may still consider eligible determine suffer significant financial and/or transportation hardship typical course CFRT HFRT ( judgment treat physician ) . Patients live outside Commonwealth Kentucky eligible fit aforementioned condition . Appalachian county KY include : Adair , Bath , Bell , Boyd , Breathitt , Carter , Casey , Clark , Clay , Clinton , Cumberland , Edmonson , Elliott , Estill , Fleming , Floyd , Garrard , Green , Greenup , Harlan , Hart , Jackson , Johnson , Knott , Knox , Laurel , Lawrence , Lee , Leslie , Letcher , Lewis , Lincoln , Madison , Magoffin , Martin , McCreary , Menifee , Metcalfe , Monroe , Montgomery , Morgan , Nicholas , Owsley , Perry , Pike , Powell , Pulaski , Robertson , Rockcastle , Rowan , Russell , Wayne , Whitley , Wolfe . Men eligible study . Women one follow condition ineligible study . 1 . T3 , stage III , stage IV breast cancer 2 . More 3 histologically positive axillary node 3 . Axillary node definite evidence microscopic macroscopic extracapsular extension 4 . One positive nonaxillary sentinel node ( ) ( Note intramammary node stag axillary node . ) 5 . Palpable radiographically suspicious ipsilateral contralateral axillary , supraclavicular , infraclavicular , internal mammary node , unless histologic confirmation node negative tumor 6 . Suspicious microcalcifications , density , palpable abnormality ( ipsilateral contralateral breast ) unless biopsied found benign 7 . Nonepithelial breast malignancy sarcoma lymphoma 8 . Proven multicentric carcinoma ( invasive cancer DCIS ) one quadrant separate 4 centimeter 9 . Paget 's disease nipple 10 . Synchronous bilateral invasive noninvasive breast cancer 11 . History invasive breast cancer DCIS ( Patients history lobular carcinoma situ ( LCIS ) treat surgery alone eligible . ) 12 . Surgical margin microscopically assess positive pathologic evaluation ( If surgical margin render free disease reexcision , patient eligible . ) 13 . Treatment plan include regional nodal irradiation 14 . Current therapy hormonal agent raloxifene ( EvistaÂ® ) , tamoxifen , selective estrogen receptor modulators ( SERMs ) , either osteoporosis breast cancer prevention ( Patients eligible medication discontinue prior enrollment . ) 15 . Cosmetic breast implant ( Patients implant remove eligible . ) 16 . Prior breast thoracic RT condition 17 . Collagen vascular disease , specifically dermatomyositis CPK level normal active skin rash , systemic lupus erythematosis , scleroderma 18 . Pregnancy lactation time propose randomization . Women reproductive potential must agree use effective nonhormonal method contraception therapy . 19 . Psychiatric addictive disorder condition , opinion investigator , would preclude patient meeting study requirement</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>breast neoplasm</keyword>
	<keyword>breast tumor</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>radiation</keyword>
	<keyword>accelerate</keyword>
	<keyword>lumpectomy</keyword>
</DOC>